A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
Mice were immunized with a combination of self-amplifying (sa) RNA constructs for the F1 and V antigens of Yersinia pestis at a dose level of 1 μg or 5 μg or with the respective protein sub-units as a reference vaccine. The immunization of outbred OF1 mice on day 0 and day 28 with the lowest dose us...
Main Authors: | Robin John Shattock, Voahangy Andrianaivoarimanana, Paul F. McKay, Lovasoa Nomena Randriantseheno, Valarmathy Murugaiah, K. Samnuan, Paul Rogers, John S. Tregoning, Minoarisoa Rajerison, Kristoffer M. Moore, Thomas Robert Laws, E. Diane Williamson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2023.1247041/full |
Similar Items
-
Exposure to Yersinia pestis increases resistance to plague in black rats and modulates transmission in Madagascar
by: Voahangy Andrianaivoarimanana, et al.
Published: (2018-12-01) -
Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
by: Yoann Aldon, et al.
Published: (2021-09-01) -
Pneumonic Plague Transmission, Moramanga, Madagascar, 2015
by: Beza Ramasindrazana, et al.
Published: (2017-03-01) -
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial
by: Rindra Vatosoa Randremanana, et al.
Published: (2020-08-01) -
Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses
by: Yalan Liu, et al.
Published: (2023-06-01)